- Wockhardt opts for self-commercialisation of Zaynich over licensing to maximise value: Chairman Moneycontrol.com
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics market The Economic Times
- How Wockhardt created India’s first fully homegrown drug Forbes India
- ‘USFDA nod for Zaynich a major boost’ The Times of India
- CDSCO grants marketing authorisation to Wockhardt’s drug ZAYNICH® for treatment of complicated UTIs BioSpectrum India